JP Patent

JP5358095B2 — 糖尿病、メタボリック症候群、および他の状態を治療するための方法および組成物

Assigned to コーテンド アーベー （ピーユービーエル） · Expires 2013-12-04 · 12y expired

What this patent protects

Patent listed against Recorlev.

Drugs covered by this patent

Patent Metadata

Patent number
JP5358095B2
Jurisdiction
JP
Classification
—
Expires
2013-12-04
Drug substance claim
No
Drug product claim
No
Assignee
コーテンド アーベー （ピーユービーエル）
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.